SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired IDEA Pharma (“IDEA”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. IDEA, headquartered in London, United Kingdom, specializes in pharmaceutical path-to-market strategy and innovation. This acquisition strengthens SAI’s capacity to offer comprehensive strategic services to its biopharma clients, supporting the process from drug discovery to market launch and lifecycle management.
Read the full article: SAI MedPartners Expands Strategic Service Offering through Acquisition of IDEA Pharma //
Source: https://www.businesswire.com/news/home/20241104264819/en/SAI-MedPartners-Expands-Strategic-Service-Offering-Through-Acquisition-of-IDEA-Pharma